Breaking News Instant updates and real-time market news.

AON

Aon plc

$175.38

-0.14 (-0.08%)

, MMC

Marsh & McLennan

$93.76

-0.62 (-0.66%)

04:55
04/19/19
04/19
04:55
04/19/19
04:55

Willis Towers Watson

Analyst Klauber holds a group luncheon with the Executive Vice President/Risk Practices Leader at Lockton Companies, Mark Moitoso, who will provide insights into the brokerage industry, in New York on April 19 at 12 pm hosted by William Blair.

AON

Aon plc

$175.38

-0.14 (-0.08%)

MMC

Marsh & McLennan

$93.76

-0.62 (-0.66%)

WLTW

Willis Towers Watson

$177.37

0.45 (0.25%)

  • 19

    Apr

  • 25

    Apr

  • 26

    Apr

  • 01

    May

  • 07

    May

  • 16

    May

  • 20

    May

  • 11

    Jun

AON Aon plc
$175.38

-0.14 (-0.08%)

02/04/19
02/04/19
UPGRADE
Target $200

Buy
Aon plc upgraded to Buy at MKM Partners on good organic growth
As previously reported, MKM Partners analyst Harry Fong upgraded Aon to Buy from Neutral and raised his price target to $200 from $155. The analyst cites the company's "good organic growth" of 6% reported in Q4 as well as its "very strong" free cash flow generation. As its restructuring program phases out, Fong believes that Aon may be on a path toward " upward sloping glide for earnings and cash flow," adding that the company's valuation profile has also improved.
02/04/19
02/04/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. ConocoPhillips (COP) upgraded to Buy from Neutral at Goldman Sachs with analyst Neil Mehta citing better than expected Q4 results to reflect better long-term differential assumptions outside of the U.S., a reduced operating cost outlook given recent trends, higher oil volumes in the Lower 48, Alaska, Asia to reflect project-by-project builds and slightly higher Australia LNG distribution payments up to Conoco. 2. Aon plc (AON) upgraded to Buy from Neutral at MKM Partners with analyst Harry Fong citing the company's "good organic growth" of 6% reported in Q4 as well as its "very strong" free cash flow generation. 3. Intercept (ICPT) upgraded to Strong Buy from Outperform at Raymond James with analyst Steven Seedhouse citing his "unusually high amount of conviction in REGENERATE" trial data, noting that all the attempts to test his confidence in the investment story have only made him more bullish. 4. Intuit (INTU) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Keith Weiss saying new products, tax code changes and a more benign competitive environment position the company to exceed conservative revenue expectations in FY19. 5. Addus HomeCare (ADUS) upgraded to Outperform from Neutral at Baird with analyst Matthew Gillmor saying he believes secular drivers will support attractive growth and bullish fundamentals for the home care sector. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/08/19
DBAB
02/08/19
UPGRADE
Target $164
DBAB
Hold
Deutsche Bank upgrades Willis Towers Watson to Hold, boosts target to $164
Deutsche Bank analyst Joshua Shanker last night upgraded Willis Towers Watson (WLTW) to Hold from Sell and raised his price target for the shares to $164 from $149. With 2018 coming to a close, the free cash flow content of Willis Towers Watson's earnings has improved to a point where the "valuation discount to its peers is no longer materially under-representative," Shanker tells investors in a research note. A deeper valuation gap for Willis relative to peers shares Aon plc (AON) and Marsh & McLennan (MMC) "seems unmerited at this time," adds the analyst.
03/05/19
WELS
03/05/19
NO CHANGE
WELS
Wells Fargo not convinced Willis Towers Watson deal with Aon would work
After Bloomberg reported that Aon (AON) is considering a bid to buy Willis Towers Watson (WLTW), Wells Fargo analyst Elyse Greenspan said the movements in both stocks following the report do not indicate to her that the market thinks a deal is coming. Overall, she sees regulatory issues being a big overhang for a deal that would combine the second and third largest insurance brokers and she is not convinced such a deal could get completed. If she were to be wrong, and such a deal comes together, Greenspan said she believes the net winner would be Arthur J. Gallagher (AJG), as they can take advantage by either buying additional businesses or taking people that want to leave or business that gets lost. Wells Fargo has Market Perform ratings on Aon and Willis and an Outperform rating on Gallagher shares.
MMC Marsh & McLennan
$93.76

-0.62 (-0.66%)

01/15/19
COMP
01/15/19
INITIATION
Target $86
COMP
Neutral
Marsh & McLennan initiated with a Neutral at Compass Point
Compass Point analyst Bijan Moazami initiated Marsh & McLennan with a Neutral and $86 price target saying he expects the JLT acquisition to be a "monumental" challenge and notes margin expansion has "halted."
04/05/19
WELS
04/05/19
DOWNGRADE
Target $95
WELS
Market Perform
Marsh & McLennan downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Elyse Greenspan downgraded Marsh & McLennan (MMC) to Market Perform from Outperform with an unchanged price target of $95. With the shares up 19% year-to-date, the analyst is taking the time to move to the sidelines. She views Marsh & McLennan's acquisition of JLT as a long-term positive but points out that "no large brokerage transactions have taken place without some hiccups along the way." For investors looking for exposure to the brokers, Greenspan continues to have an Outperform rating on Arthur J Gallagher (AJG).
04/08/19
GSCO
04/08/19
INITIATION
Target $98
GSCO
Neutral
Marsh & McLennan reinstated with a Neutral at Goldman Sachs
Goldman Sachs analyst Yaron Kinar reinstated Marsh & McLennan with a Neutral and $98 price target.
WLTW Willis Towers Watson
$177.37

0.45 (0.25%)

04/02/19
SBSH
04/02/19
NO CHANGE
Target $200
SBSH
Buy
Willis Towers Watson price target raised to $200 from $192 at Citi
Citi analyst James Naklicki raised his price target for Willis Towers Watson to $200 from $192 saying he has a favorable view of the company's Tranzact acquisition. Tranzact is highly levered to the "rapidly growing" Medicare Advantage and Medicare Supplemental market, Naklicki tells investors in a research note. He keeps a Buy rating on Willis Towers Watson.
04/08/19
MKMP
04/08/19
NO CHANGE
Target $210
MKMP
Buy
Willis Towers Watson price target raised to $210 from $190 at MKM Partners
MKM Partners analyst Harry Fong raised his price target on Willis Towers Watson to $210and kept his Buy rating after its latest TRANZACT acquisition, saying the deal positions the company for two new Health Reimbursement Arrangements to be launched in the next two years. The analyst notes that TRANZACT will "enhance Willis's capabilities in the direct-to-consumer channel with Medicare and other products", complementing the company's Liazon and Extend Health units facilitating transition from group health plan due to retirement into a Medicare plan. Fong also states that while Medicare business grows at a low single-digit rate, the potential growth rate for the individual HRA business could be "significantly higher."
04/08/19
RBCM
04/08/19
NO CHANGE
RBCM
Outperform
eHealth guidance still 'looks conservative', says RBC Capital
RBC Capital analyst Frank Morgan kept his Outperform rating on eHealth (EHTH), stating that its valuation is supported by the $1.4B deal by WillisTowers Watson (WLTW) to acquire Tranzact which is also validating his bullish MA thesis. The analyst also notes that the stock has performed well in an otherwise "difficult healthcare tape", in part because of its "strong growth prospects in a niche not perceived as a problem with the healthcare system."
04/17/19
RHCO
04/17/19
NO CHANGE
RHCO
Buy
eHealth pullback presents 'very attractive' entry point, says SunTrust
SunTrust analyst Tobey Sommer said he views the mid-teen percentage decline in eHealth (EHTH) shares amid worries about Medicare for all proposals as presenting a "very attractive" entry point, noting that applying the same multiple paid by Willis Towers Watson (WLTW) for Tranzact implies a $62 share price for eHealth. While eHealth has a lower EBITDA margin, its revenue is growing faster and it has exposure in the individual and small business markets as well as the main Medicare business. The analyst, who believes eHealth's multi-year top-line growth outlook is substantially superior to consensus forecasts, driven by superior Medicare growth, keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

UBER

Uber

$41.40

0.94 (2.32%)

17:49
05/24/19
05/24
17:49
05/24/19
17:49
Hot Stocks
Uber board director Ryan Graves intends to resign »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

APTO

Aptose Biosciences

$2.01

0.03 (1.52%)

17:46
05/24/19
05/24
17:46
05/24/19
17:46
Syndicate
Aptose Biosciences files for $40M at-the-market common stock offering »

Piper Jaffray and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

TRNX

Taronis Technologies

$0.48

0.004 (0.84%)

17:26
05/24/19
05/24
17:26
05/24/19
17:26
Syndicate
Breaking Syndicate news story on Taronis Technologies »

Taronis Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:25
05/24/19
05/24
17:25
05/24/19
17:25
Hot Stocks
U.S. Energy discloses Nasdaq notice regarding delayed 10-Q filing »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

17:22
05/24/19
05/24
17:22
05/24/19
17:22
Periodicals
Apple sued over allegedly selling users' iTunes data, Bloomberg says »

Apple is being sued by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SPCB

SuperCom

$1.17

-0.005 (-0.43%)

17:21
05/24/19
05/24
17:21
05/24/19
17:21
Hot Stocks
SuperCom discloses Nasdaq notice regarding delayed 20-F filing »

SuperCom received a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USEG

U.S. Energy

$0.45

0.0373 (9.10%)

17:20
05/24/19
05/24
17:20
05/24/19
17:20
Hot Stocks
U.S. Energy receives noncompliance notice from Nasdaq »

U.S. Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:18
05/24/19
05/24
17:18
05/24/19
17:18
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOV

Myovant Sciences

$12.39

-0.465 (-3.62%)

17:17
05/24/19
05/24
17:17
05/24/19
17:17
Syndicate
Breaking Syndicate news story on Myovant Sciences »

Myovant Sciences files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVS

Novartis

$87.49

3.03 (3.59%)

, QGEN

Qiagen

$38.22

-0.255 (-0.66%)

16:57
05/24/19
05/24
16:57
05/24/19
16:57
Hot Stocks
Qiagen launches diagnostic for PIK3CA biomarkers in breast cancer »

Qiagen (QGEN) announced…

NVS

Novartis

$87.49

3.03 (3.59%)

QGEN

Qiagen

$38.22

-0.255 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

  • 20

    Jun

  • 06

    Aug

AVH

Avianca

$3.96

0.91 (29.84%)

16:56
05/24/19
05/24
16:56
05/24/19
16:56
Periodicals
ANAC suspends flights, operations of Avianca Brasil, Reuters reports »

Brazil's ANAC said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$179.03

-0.64 (-0.36%)

16:53
05/24/19
05/24
16:53
05/24/19
16:53
Periodicals
Apple acquires startup Tueo Health, CNBC reports »

Apple has bought Tueo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

SHSP

SharpSpring

$16.37

-0.24 (-1.44%)

16:52
05/24/19
05/24
16:52
05/24/19
16:52
Syndicate
Breaking Syndicate news story on SharpSpring »

SharpSpring files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

CREG

China Recycling Energy

$0.48

0.005 (1.05%)

16:41
05/24/19
05/24
16:41
05/24/19
16:41
Syndicate
Breaking Syndicate news story on China Recycling Energy »

China Recycling Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FENC

Fennec

$3.88

(0.00%)

16:36
05/24/19
05/24
16:36
05/24/19
16:36
Conference/Events
Fennec management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 18

    Jun

TD

Toronto-Dominion

$56.66

0.65 (1.16%)

16:35
05/24/19
05/24
16:35
05/24/19
16:35
Syndicate
Breaking Syndicate news story on Toronto-Dominion »

Toronto-Dominion files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
05/24/19
05/24
16:30
05/24/19
16:30
Options
Preliminary option volume of 15.7M today »

Preliminary option volume…

CBUS

Cibus

$0.00

(0.00%)

16:25
05/24/19
05/24
16:25
05/24/19
16:25
Syndicate
Cibus requests withdrawal of registration statement »

The company's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$355.14

4.57 (1.30%)

16:23
05/24/19
05/24
16:23
05/24/19
16:23
Periodicals
Boeing 737 MAX return delayed by FAA expanding review, WSJ reports »

A review of Boeing's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

FB

Facebook

$181.03

0.14 (0.08%)

, BA

Boeing

$355.14

4.57 (1.30%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
On The Fly
Fly Intel: Wall Street's top stories for Friday »

U.S. stocks, which had a…

FB

Facebook

$181.03

0.14 (0.08%)

BA

Boeing

$355.14

4.57 (1.30%)

UAL

United Continental

$80.77

-0.14 (-0.17%)

SMI

SMIC

$5.23

-0.26 (-4.74%)

HPQ

HP Inc.

$20.03

0.835 (4.35%)

HPE

HP Enterprise

$14.36

0.03 (0.21%)

NVS

Novartis

$87.49

3.03 (3.59%)

CNC

Centene

$56.84

1.39 (2.51%)

WCG

WellCare

$275.45

0.99 (0.36%)

TSS

TSYS

$113.42

13.81 (13.86%)

GPN

Global Payments

$153.42

5.45 (3.68%)

HIBB

Hibbett Sports

$23.91

4.07 (20.51%)

DVAX

Dynavax

$5.77

-0.59 (-9.28%)

FL

Foot Locker

$44.39

-8.455 (-16.00%)

SPLK

Splunk

$119.13

-9.55 (-7.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 24

    May

  • 29

    May

  • 30

    May

  • 30

    May

  • 30

    May

  • 31

    May

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 08

    Jun

  • 09

    Jun

  • 10

    Jun

  • 13

    Jun

  • 14

    Jun

  • 24

    Jun

  • 24

    Jun

  • 09

    Jul

  • 09

    Jul

  • 23

    Jul

  • 13

    Nov

VIX

Volatility Index S&P 500 Options

$0.00

(0.00%)

16:20
05/24/19
05/24
16:20
05/24/19
16:20
Options
Closing CBOE SPX and VIX Index summary for May 24th »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

16:17
05/24/19
05/24
16:17
05/24/19
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

16:16
05/24/19
05/24
16:16
05/24/19
16:16
Technical Analysis
NYSE market internals summary »

Volume was below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHE

Regional Health Properties

$2.06

0.09 (4.57%)

16:15
05/24/19
05/24
16:15
05/24/19
16:15
Hot Stocks
Regional Health Properties receives NYSE notice over late Form 10-Q filing »

Regional Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBIO

Translate Bio

$9.12

-0.09 (-0.98%)

16:14
05/24/19
05/24
16:14
05/24/19
16:14
Syndicate
Breaking Syndicate news story on Translate Bio »

Translate Bio files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.